Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01377441 · ClinicalTrials.gov registry record · Phase 4

Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia.

A Phase 4 study, sponsored by NYU Langone Health.

Terminated
Registry status
Phase 4
Development phase
6
Enrollment target

NCT01377441: Clinical Trial Phase 4 study, sponsored by NYU Langone Health.

NCT01377441 is a Phase 4 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 6 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01377441, a Phase 4 study, was terminated before completion, sponsored by NYU Langone Health.

TERMINATED
Registry status
Phase 4
Development phase
6 participants
Enrollment target

Study Summary

The administration of anti-inflammatory drugs such as ibuprofen before and after surgery has not been studied extensively. Subjects are being asked to participate in this study because they are scheduled for surgery and because the investigators want to study ways to improve recovery from surgery. Ibuprofen will be given several times before and after surgery. The investigators will ask questions to determine recovery and the investigators will draw blood to determine inflammatory response.

Primary Outcome

Concentration of the cytokines TNF-alpha, IL-1Beta, IL-2, IL-6, IL-10, and IFN-gamma as well as prostaglandin E2 at different time points will be our primary outcome. Changes in mediator levels in the IV ibuprofen versus placebo groups will be compared. Plasma samples will be collected before administration of any drug (after placement of IV lines), at the end of the surgery, and on the first postoperative day.

Interventions

  • DRUG Ibuprofen
  • DRUG Placebo/Saline solution

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2011-09
Est. Completion 2013-05
Phase Phase 4
NYU Langone Health

1,164 total trials

Why NCT01377441 stopped before completion

NCT01377441 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Ibuprofen is the first listed.

NCT01377441 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01377441 about?

NCT01377441 is a clinical study titled "Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia.". The administration of anti-inflammatory drugs such as ibuprofen before and after surgery has not been studied extensively. Subjects are being asked to participate in this study because they are scheduled for surgery and because the investigators want to study ways to improve recovery from surgery. I...

What is the current status of trial NCT01377441?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2011-09. Estimated completion is 2013-05.

What interventions are being tested in trial NCT01377441?

The interventions under investigation include: Ibuprofen (DRUG), Placebo/Saline solution (DRUG).

Who is sponsoring clinical trial NCT01377441?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01377441's enrollment target sits among peer trials

6 1983rd of 2000 higher than 12 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01377441, the US trial registry maintained by the National Library of Medicine. NCT01377441 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.